arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Denali Therapeutics Inc.

DNLI Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$19.52
▼ -3.1% Today
as of Jun 7, 07:13 ET
Last 30 days -2.69% Apr 28 → Jun 05
$17.88 $18.73 $19.58 $20.42 $21.27 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$19.94
High
$19.94
Low
$19.24
Volume
$2M
Avg Vol
$2M
Mkt Cap
$3.3B
P/E (TTM)
Beta
52w High
$23.77
52w Low
$12.58
Div Yield
Shares Out
$159M

Overview

52-week range
$13
$24
62% of range
Avg surprise (last 2)
-2.2%
Avg reaction (last 2)
-8.0%
0% positive
Latest IV / EM
71%
EM ±9.9% · $20 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.78$-0.26$0.26$0.78$1.30 Actual $1.30Actual $-0.72Actual $-0.68Actual $-0.59Actual $-0.63Actual $-0.78Est $-0.71Actual $-0.72Actual $-0.74Actual $-0.69Est $-0.73 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-133M$-126M$-118M$-111M$-104M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-0.69 $-0.73 +5.5% +11.5% -3.4% earnings
Tue Sep 30, 2025Sep 2025 $-0.74 financials
Mon Jun 30, 2025Jun 2025 $-0.72 financials
Tue May 6, 2025Mar/2025 $-0.78 $-0.71 -9.9% -12.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.63 financials
Sun Jun 30, 2024Jun 2024 $-0.59 financials
Sun Mar 31, 2024Mar 2024 $-0.68 financials
Sat Sep 30, 2023Sep 2023 $-0.72 financials
Fri Jun 30, 2023Jun 2023 $1.30 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-137M$-137M$-135M$-146M$-123M$-117M
Net income$-128M$-127M$-124M$-133M$-107M$-99M
EPS (diluted)$-0.69$-0.74$-0.72$-0.78$-0.63$-0.59

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$388M$205M$91M$141M$57M$175M$91M$75M
Inventory
Total current assets$1.02B$901M$883M$935M$879M$864M$869M$928M
Total assets$1.27B$1.14B$1.06B$1.17B$1.27B$1.37B$1.45B$1.50B
Long-term debt
Total liabilities$340M$131M$129M$139M$149M$144M$136M$116M
Total equity$926M$1.01B$926M$1.03B$1.12B$1.23B$1.32B$1.39B

Implied volatility — last 90 days

66%68%71%73%76% Jun 07 — IV 71% · EM ±9.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.